Agenus, Inc. (AGEN)
3.93
-0.10
(-2.48%)
USD |
NASDAQ |
Dec 09, 15:27
Agenus Shareholders Equity (Quarterly): -274.14M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -7.72M |
| Armata Pharmaceuticals, Inc. | -95.59M |
| Bionano Genomics, Inc. | 49.80M |
| Twist Bioscience Corp. | 472.96M |
| AIM ImmunoTech, Inc. | -6.077M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 233.89M |
| Total Liabilities (Quarterly) | 514.76M |
| Debt to Equity Ratio | -1.244 |
| Current Ratio | 0.4665 |
| Net Debt Paydown Yield | 11.18% |